A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)
Saiama N. Waqar
◽
Mary W. Redman
◽
Susanne M. Arnold
◽
Fred R. Hirsch
◽
Philip C. Mack
◽
...